Response to antifibrotic therapy and decrease of circulating BAG3 protein levels in systemic sclerosis patients with reduced forced vital capacity

Biomed Pharmacother. 2024 Apr 11;174:116578. doi: 10.1016/j.biopha.2024.116578. Online ahead of print.NO ABSTRACTPMID:38608524 | DOI:10.1016/j.biopha.2024.116578
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Source Type: research